Septerna's shares roseate astir 31% successful their marketplace debut connected Friday, giving nan Goldman Sachs-backed biotech patient a valuation of $970 million.
This communicative appeared connected reuters.com, 2024-10-25 16:25:30.
Septerna's shares roseate astir 31% successful their marketplace debut connected Friday, giving nan Goldman Sachs-backed biotech patient a valuation of $970 million.
This communicative appeared connected reuters.com, 2024-10-25 16:25:30.